FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Bafna Pharmaceuticals IPO and MCX IPO.
Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while MCX IPO is a Mainline Book Built Issue proposed to list at BSE.
Bafna Pharmaceuticals IPO | MCX IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | BSE | BSE |
Lead Managers | Keynote Financial Services Ltd Ashika Capital Ltd |
Citigroup Global Markets India Private Limited Edelweiss Financial Services Ltd Morgan Stanley India Company Pvt Ltd |
Registrar | Cameo Corporate Services Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the MCX IPO is up to ₹663.31 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of MCX IPO is ₹1,032.00 per share.
Bafna Pharmaceuticals IPO | MCX IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹860.00 per share | |
Issue Price (Upper) | ₹1,032.00 per share | |
Issue Price (Final) | ₹40.00 per share | ₹1,032.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 6 shares | |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 64,00,000 shares | 64,27,378 shares |
Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹663.31 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while MCX IPO opens on Feb 22, 2012. The closing date of Bafna Pharmaceuticals IPO and MCX IPO is May 30, 2008, and Feb 24, 2012, respectively.
Bafna Pharmaceuticals IPO | MCX IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | May 27, 2008 | Feb 22, 2012 |
Issue Close | May 30, 2008 | Feb 24, 2012 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to MCX IPO P/E ratio of .
Bafna Pharmaceuticals IPO | MCX IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
Read MCX Annual Reports |
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 71.07% | 31.18% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 42.6% | 26% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 10.65%% | 20.77%% |
In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in MCX IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 21,62,083 shares in MCX IPO.
Bafna Pharmaceuticals IPO | MCX IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 21,62,083 shares | |
NII | 9,26,607 shares | |
RII | 21,62,082 shares | |
Employee | 2,50,000 shares | |
Others | ||
Total | 55,00,772 shares |
Bafna Pharmaceuticals IPO subscribed in total, whereas MCX IPO subscribed 54.13x.
Bafna Pharmaceuticals IPO | MCX IPO | |
---|---|---|
QIB (times) | 49.12x | |
NII (times) | 150.35x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 24.14x | |
Employee (times) | 0.18x | |
Other (times) | ||
Total (times) | 54.13x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|